SS&C Technologies Total Cost of Revenue decreased by 2.1% to $845.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.2%, from $766.80M to $845.30M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 5.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $664.00M | $640.40M | $663.00M | $675.20M | $704.40M | $697.20M | $690.90M | $725.70M | $721.50M | $711.50M | $692.30M | $727.80M | $753.20M | $761.60M | $775.80M | $766.80M | $799.90M | $820.20M | $863.70M | $845.30M |
| QoQ Change | — | -3.6% | +3.5% | +1.8% | +4.3% | -1.0% | -0.9% | +5.0% | -0.6% | -1.4% | -2.7% | +5.1% | +3.5% | +1.1% | +1.9% | -1.2% | +4.3% | +2.5% | +5.3% | -2.1% |
| YoY Change | — | — | — | — | +6.1% | +8.9% | +4.2% | +7.5% | +2.4% | +2.1% | +0.2% | +0.3% | +4.4% | +7.0% | +12.1% | +5.4% | +6.2% | +7.7% | +11.3% | +10.2% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Software Enabled Services | $654.00M | $661.90M | $669.10M | $667.30M | $693.90M | $714.20M | $763.90M | $740.50M |
| License And Maintenance | $99.20M | $99.70M | $106.70M | $99.50M | — | — | — | — |
| Total | $753.20M | $761.60M | $775.80M | $766.80M | $799.90M | $820.20M | $863.70M | $845.30M |